Intellia Therapeutics Inc (NTLA)
23.29
+0.79
(+3.51%)
USD |
NASDAQ |
May 02, 16:00
23.44
+0.15
(+0.64%)
After-Hours: 20:00
Intellia Therapeutics 1 Year Total Returns (Daily): -37.05% for May 2, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 02, 2024 | -37.05% |
May 01, 2024 | -40.38% |
April 30, 2024 | -43.31% |
April 29, 2024 | -41.77% |
April 26, 2024 | -42.70% |
April 25, 2024 | -44.80% |
April 24, 2024 | -42.02% |
April 23, 2024 | -42.03% |
April 22, 2024 | -41.22% |
April 19, 2024 | -42.72% |
April 18, 2024 | -43.58% |
April 17, 2024 | -45.22% |
April 16, 2024 | -42.85% |
April 15, 2024 | -39.94% |
April 12, 2024 | -29.81% |
April 11, 2024 | -29.17% |
April 10, 2024 | -28.63% |
April 09, 2024 | -27.48% |
April 08, 2024 | -29.64% |
April 05, 2024 | -30.76% |
April 04, 2024 | -30.98% |
April 03, 2024 | -32.65% |
April 02, 2024 | -32.65% |
April 01, 2024 | -26.97% |
March 28, 2024 | -23.63% |
Date | Value |
---|---|
March 27, 2024 | -27.27% |
March 26, 2024 | -31.44% |
March 25, 2024 | -29.95% |
March 22, 2024 | -27.56% |
March 21, 2024 | -30.51% |
March 20, 2024 | -27.41% |
March 19, 2024 | -30.65% |
March 18, 2024 | -31.30% |
March 15, 2024 | -30.77% |
March 14, 2024 | -31.42% |
March 13, 2024 | -25.16% |
March 12, 2024 | -22.45% |
March 11, 2024 | -17.53% |
March 08, 2024 | -25.54% |
March 07, 2024 | -25.00% |
March 06, 2024 | -25.27% |
March 05, 2024 | -30.28% |
March 04, 2024 | -25.35% |
March 01, 2024 | -19.85% |
February 29, 2024 | -20.04% |
February 28, 2024 | -18.35% |
February 27, 2024 | -21.25% |
February 26, 2024 | -26.71% |
February 23, 2024 | -33.03% |
February 22, 2024 | -30.20% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-72.42%
Minimum
Dec 23 2022
860.5%
Maximum
Sep 03 2021
74.58%
Average
-20.04%
Median
Feb 29 2024
1 Year Total Returns (Daily) Benchmarks
Moderna Inc | -4.39% |
Regeneron Pharmaceuticals Inc | 17.43% |
NeuroMetrix Inc | -59.80% |
Repligen Corp | 5.78% |
Pacific Biosciences of California Inc | -84.42% |